Almost a year after announcing a $4 billion deal, Sun Pharmaceutical Industries on Tuesday said merger of Ranbaxy with itself has been 'consummated' following receipt of requisite approvals. In a......
Sun Pharmaceutical Industries has received RBI nod for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of their......
The merger gets Punjab & Haryana High Court go-ahead; deal to close after brand dilutions The $4-billion merger between Sun Pharmaceutical Industries and Ranbaxy Laboratories has crossed the final......
The US Federal Trade Commission (FTC) has completed its review of the proposed $4 billion acquisition of Ranbaxy Laboratories by Sun Pharma and granted early termination of the waiting period under......
An American federal trade regulator on Saturday imposed conditions on Sun Pharmaceuticals' acquisition of Ranbaxy on the grounds that the $4 billion proposed deal would likely be anti-competitive.......